Dr. Talbots Mucus Cold Relief
NDC 70797-313, Eupatorium perf, Hepar sulphuris calcareum, Kali bichromicum, Marrubium vulgare, Phosphorus, Pulsatilla, Rumex crispus, Sambucus nigra, Calcarea sulphurica, Ferrum phosphoricum, Kali muriaticum, liquid, from Talbot's Pharmaceuticals Family Products, LLC..
- Product NDC
- 70797-313
- Status
- Listed
- Labeler
- Talbot's Pharmaceuticals Family Products, LLC.
- Dosage form
- LIQUID
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Application
- —
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70797-313 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- EUPATORIUM PERFOLIATUM FLOWERING TOP12 [hp_X]/118mL
- SAMBUCUS NIGRA FLOWERING TOP12 [hp_X]/118mL
- CALCIUM SULFATE ANHYDROUS12 [hp_X]/118mL
- POTASSIUM CHLORIDE6 [hp_X]/118mL
- MARRUBIUM VULGARE12 [hp_X]/118mL
- PHOSPHORUS30 [hp_X]/118mL
- RUMEX CRISPUS ROOT12 [hp_X]/118mL
- FERROSOFERRIC PHOSPHATE12 [hp_X]/118mL
- CALCIUM SULFIDE12 [hp_X]/118mL
- POTASSIUM DICHROMATE12 [hp_X]/118mL
- ANEMONE PULSATILLA12 [hp_X]/118mL
Pharmacologic classes
Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70797-313-01 | 70797031301 | 1 BOTTLE in 1 CARTON (70797-313-01) / 118 mL in 1 BOTTLE (70797-313-04) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 70797-313 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70797-313 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70797-313. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.